(2026). Cost–Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan. Dermatology and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Cost–Effectiveness Analysis of Bimekizumab Against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan."
Dermatology and Therapy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Cost–Effectiveness Analysis of Bimekizumab Against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan."
Dermatology and Therapy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.